| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens
|
van den Berg, Remco M.
|
|
2011
|
72 |
3 |
p. 316-321
6 p.
|
artikel
|
| 2 |
Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
|
Xu, Yaping
|
|
2011
|
72 |
3 |
p. 327-332
6 p.
|
artikel
|
| 3 |
Contents
|
|
|
2011
|
72 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 4 |
Define relative incomplete resection by highest mediastinal lymph node metastasis for non-small cell lung cancers: Rationale based on prognosis analysis
|
Zheng, Hui
|
|
2011
|
72 |
3 |
p. 348-354
7 p.
|
artikel
|
| 5 |
Diverging prognostic impacts of hypoxic markers according to NSCLC histology
|
Andersen, Sigve
|
|
2011
|
72 |
3 |
p. 294-302
9 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2011
|
72 |
3 |
p. iii-
1 p.
|
artikel
|
| 7 |
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component
|
Yoshida, Akihiko
|
|
2011
|
72 |
3 |
p. 309-315
7 p.
|
artikel
|
| 8 |
Gene associated with retinoid–interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo
|
Wang, Tong
|
|
2011
|
72 |
3 |
p. 287-293
7 p.
|
artikel
|
| 9 |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu, Shang-Gin
|
|
2011
|
72 |
3 |
p. 333-339
7 p.
|
artikel
|
| 10 |
Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer
|
Kaptein, Ad A.
|
|
2011
|
72 |
3 |
p. 384-390
7 p.
|
artikel
|
| 11 |
Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung
|
Usuda, Jitsuo
|
|
2011
|
72 |
3 |
p. 355-359
5 p.
|
artikel
|
| 12 |
Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study
|
Lestuzzi, Chiara
|
|
2011
|
72 |
3 |
p. 340-347
8 p.
|
artikel
|
| 13 |
No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis
|
Yin, Ming
|
|
2011
|
72 |
3 |
p. 370-377
8 p.
|
artikel
|
| 14 |
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis
|
Garassino, Marina Chiara
|
|
2011
|
72 |
3 |
p. 378-383
6 p.
|
artikel
|
| 15 |
Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers
|
Lo, Yen-Li
|
|
2011
|
72 |
3 |
p. 280-286
7 p.
|
artikel
|
| 16 |
Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: A systematic review
|
Knez, Lea
|
|
2011
|
72 |
3 |
p. 271-279
9 p.
|
artikel
|
| 17 |
Risk of lung cancer in patients with preinvasive bronchial lesions followed by autofluorescence bronchoscopy and chest computed tomography
|
Alaa RM, Mohamed
|
|
2011
|
72 |
3 |
p. 303-308
6 p.
|
artikel
|
| 18 |
Sojourn time and lead time projection in lung cancer screening
|
Wu, Dongfeng
|
|
2011
|
72 |
3 |
p. 322-326
5 p.
|
artikel
|
| 19 |
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
|
Camps, Carlos
|
|
2011
|
72 |
3 |
p. 365-369
5 p.
|
artikel
|
| 20 |
The search for improved systemic therapy of non-small cell lung cancer—What are today's options?
|
Früh, M.
|
|
2011
|
72 |
3 |
p. 265-270
6 p.
|
artikel
|
| 21 |
TS expression predicts postoperative recurrence in adenocarcinoma of the lung
|
Shimokawa, Hidehiko
|
|
2011
|
72 |
3 |
p. 360-364
5 p.
|
artikel
|
Tijdschrift beschrijving